Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil modernises flagship cancer institute – bigger budget, new purchasing regime

This article was originally published in Clinica

Executive Summary

Brazil's national cancer institute (INCA) has been awarded a R$54m (US$24m) increase on its current R$330m annual budget, to invest in new centres and help meet new service quality standards. The additional funding comes with administrative reforms, said to feature a simpler regime specifically for the purchase of consumables and equipment. Ministerial decree 2,024, approved on September 26 after a 16-month passage through parliament, provides funding to build a new centre in Rio de Janeiro city, two new "high-complexity" (diagnostic and treatment) centres in Rio de Janeiro state, and an undisclosed number of "macro-regional" R&D centres across the country. Last year, INCA registered 7,556 new patients, performed around 12,000 surgical procedures, including 92 bone marrow transplants. It managed almost a half of Rio de Janeiro city's 342,000 radiotherapy procedures, and a quarter of all cases in Rio de Janeiro state.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel